The impact of molecular testing on treatment of cancer of unknown primary origin
Oncology (Williston Park)
.
2013 Aug;27(8):815-7.
Author
F Anthony Greco
1
Affiliation
1
Sarah Cannon Cancer Center and Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
PMID:
24133835
No abstract available
MeSH terms
Humans
Neoplasms, Unknown Primary*